NEO
NeoGenomics, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -25.3% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 96 | +7 | 89.82M | $1.31B | +13 | −6 |
| Q1 2026 | 92 | +1 | 80.37M | $596.13M | +7 | −6 |
| Q4 2025 | 90 | +1 | 81.69M | $948.79M | +1 | — |
| Q3 2025 | 14 | 0 | 59.68M | $460.71M | — | — |
| Q2 2025 | 11 | 0 | 47.11M | $344.36M | +2 | −2 |
| Q1 2025 | 8 | 0 | 15.46M | $146.75M | +2 | −2 |
| Q4 2024 | 8 | 0 | 10.24M | $168.75M | — | — |
| Q3 2024 | 7 | 0 | 4.10M | $60.43M | +2 | −2 |
| Q2 2024 | 7 | — | 5.49M | $76.11M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 3.05M | +1.2% | $45.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 3.05M | +1.2% | $45.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Norges Bank ✦ (passive) | 442.18K | -27.1% | $6.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 432.54K | -26.5% | $6.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 432.54K | -26.5% | $6.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 59.73K | -64.1% | $880,988 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Bridgewater Associates ✦ | 50.35K | -19.7% | $742,721 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 40.27K | New | $594,056 | 0.0% | New | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 19.23K | New | $283,584 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Millennium Management | $594,056 | 0.0% |
| Citadel Advisors | $283,584 | 0.0% |
Exited
| Point72 Asset Management | $14.31M | was 0.0% |
| Renaissance Technologies | $212,211 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 66.00K shares, $60,522 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.